FDA approves new oral antibiotic for complicated urinary tract infections
GSK and Spero Therapeutics have announced the US Food and Drug Administration’s (FDA) approval of their new oral antibiotic for complicated urinary tract infections (cUTIs). The medication, branded as Utebzi, is now the first and only oral carbapenem antibiotic available in the United States. This new treatment is designed to combat cUTIs caused by multidrug-resistant … Read more